This requires careful medical supervision and regular bloodwork to monitor metabolic markers
Final Verdict Invigor Medical gets points for policy transparency and clear pricing, but beyond that, it falls short
23431 (May 1, 2026), the FDA proposed to restrict large-scale 503B compounding of these medications, with a public comment period open through June 29, 2026
Here are the main categories founders can still build right now: Patient Intake and Eligibility Workflows You can collect health history, BMI, contraindications, prior treatment history, lab intake, and payer information to determine whether a patient is even a candidate for GLP-1 care
Most over-the-counter cold medications and supplements are safe to use during GLP-1 therapy, but inform your PlexusDx care team of any additions to your regimen